Johnson & Johnson Shows Positive Momentum in Trading

2 min read | November 25, 2024 05:34 PM PST | By Team Kalkine Media

Google News:

Johnson & Johnson Shows Positive Momentum in Trading — Image source: Shutterstock

Recent News

JPMorgan (NYSE:JPM) Leads Quiet Rotation In Financial Value Stocks

Exxon Mobil (NYSE:XOM) In Focus: What’s Catching Market Attention?

UnitedHealth (NYSE:UNH) Leads Healthcare Value Watch

Duke Energy (NYSE:DUK) Dividends Face A Key Market Test

Make Kalkine Media
My Trusted Source

Headlines

Johnson & Johnson's stock gains traction with a recent 0.8% increase in mid-day trading.

Analysts maintain various outlooks, with multiple updated price targets showcasing confidence in JNJ's future.

New analyst ratings provide insight into JNJ's potential in the healthcare sector.

Johnson & Johnson (NYSE:JNJ) saw a 0.8% rise in mid-day trading on Monday, with its stock reaching as high as $157.02 and last trading at $156.43. The company experienced a decrease in trading volume compared to its average, indicating steadiness among current shareholders.

Several research analysts have recently provided updates on JNJ, reflecting a range of perspectives on its performance. Guggenheim raised its price target on the stock, citing positive projections for the company's ongoing performance. Wolfe Research initiated coverage of Johnson & Johnson, signaling optimism with a favorable rating and a long-term outlook. Similarly, Morgan Stanley revised its target price, suggesting confidence in JNJ’s strategic developments.

Adding to these viewpoints, Cantor Fitzgerald reiterated a supportive rating, noting Johnson & Johnson’s stability and growth potential in the competitive healthcare industry. This shows a positive sentiment from analysts, as they emphasize the company's steady footing and strategic initiatives within its sector.

In total, several analysts have offered ratings for JNJ, including balanced perspectives that highlight various aspects of the company’s market position. Johnson & Johnson's status as a key player in healthcare remains supported by these analyses, underscoring its role in the sector's future growth.

This recent trading activity, combined with analyst ratings, presents a strong outlook for Johnson & Johnson as it continues to make strides in the healthcare landscape.

Disclaimer

The content, including but not limited to any articles, news, quotes, information, data, text, reports, ratings, opinions, images, photos, graphics, graphs, charts, animations and video (Content) is a service of Kalkine Media LLC (Kalkine Media, we or us) and is available for personal and non-commercial use only. The principal purpose of the Content is to educate and inform. The Content does not contain or imply any recommendation or opinion intended to influence your financial decisions and must not be relied upon by you as such. Some of the Content on this website may be sponsored/non-sponsored, as applicable, but is NOT a solicitation or recommendation to buy, sell or hold the stocks of the company(s) or engage in any investment activity under discussion. Kalkine Media is neither licensed nor qualified to provide investment advice through this platform. Users should make their own enquiries about any investments and Kalkine Media strongly suggests the users to seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice), as necessary. Kalkine Media hereby disclaims any and all the liabilities to any user for any direct, indirect, implied, punitive, special, incidental or other consequential damages arising from any use of the Content on this website, which is provided without warranties. The views expressed in the Content by the guests, if any, are their own and do not necessarily represent the views or opinions of Kalkine Media. Some of the images/music that may be used on this website are copyright to their respective owner(s). Kalkine Media does not claim ownership of any of the pictures/music displayed/used on this website unless stated otherwise. The images/music that may be used on this website are taken from various sources on the internet, including paid subscriptions or are believed to be in public domain. We have used reasonable efforts to accredit the source (public domain/CC0 status) to where it was found and indicated it, as necessary.